The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired | Acquired

Total Raised

$10.43M

Valuation

$0000 

About Genia Technologies

Genia Technologies is a private company unifying Moore's Law with molecular diagnostics to make genetic information universally available. Genia's integrated circuits enable massively parallel, single-molecule DNA sequencing. Its versatile nanopore-based platform allows for single molecule, electrical real-time analysis without the need for complicated optics, labels, amplification, or fluidics. By developing a true integrated circuit on standard semiconductor process technology, Genia brings the benefits of genome sequencing out of the lab and into the everyday world.

Genia Technologies Headquarter Location

320 Logue Avenue

Mountain View, California, 94043,

United States

650-969-6565

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Genia Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genia Technologies is included in 2 Expert Collections, including Omics.

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

S

Semiconductors, Chips, and Advanced Electronics

6,021 items

Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.

Genia Technologies Patents

Genia Technologies has filed 106 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • DNA
  • Biotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/26/2018

3/15/2022

Nanotechnology, Membrane biology, Molecular biology, Sensors, Fluid dynamics

Grant

Application Date

10/26/2018

Grant Date

3/15/2022

Title

Related Topics

Nanotechnology, Membrane biology, Molecular biology, Sensors, Fluid dynamics

Status

Grant

Latest Genia Technologies News

In Brief This Week: University of California, William Blair, HTG Molecular Diagnostics, and More

Sep 28, 2018

NEW YORK (GenomeWeb) – It was announced this week that the lawsuit filed by the Regents of the University of California against Roger Chen and Genia Technologies was dismissed on July 18, following a settlement between the parties. The suit was originally filed in late 2016 and claimed that patents assigned to Genia resulted from work Chen performed while employed at the University of California, Santa Cruz. To read the full story....

  • Where is Genia Technologies's headquarters?

    Genia Technologies's headquarters is located at 320 Logue Avenue, Mountain View.

  • What is Genia Technologies's latest funding round?

    Genia Technologies's latest funding round is Acquired.

  • How much did Genia Technologies raise?

    Genia Technologies raised a total of $10.43M.

  • Who are the investors of Genia Technologies?

    Investors of Genia Technologies include Roche Holding, Life Technologies Corporation and Columbia University.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.